Switch to:
Also traded in: Australia, Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.76
RMD's Cash-to-Debt is ranked lower than
61% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. RMD: 0.76 )
Ranked among companies with meaningful Cash-to-Debt only.
RMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.62  Med: 2.91 Max: No Debt
Current: 0.76
Equity-to-Asset 0.57
RMD's Equity-to-Asset is ranked lower than
62% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. RMD: 0.57 )
Ranked among companies with meaningful Equity-to-Asset only.
RMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.35  Med: 0.74 Max: 0.84
Current: 0.57
0.35
0.84
Debt-to-Equity 0.55
RMD's Debt-to-Equity is ranked lower than
71% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. RMD: 0.55 )
Ranked among companies with meaningful Debt-to-Equity only.
RMD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.16 Max: 1.5
Current: 0.55
0
1.5
Interest Coverage 38.18
RMD's Interest Coverage is ranked higher than
50% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.83 vs. RMD: 38.18 )
Ranked among companies with meaningful Interest Coverage only.
RMD' s Interest Coverage Range Over the Past 10 Years
Min: 15.08  Med: 63.8 Max: No Debt
Current: 38.18
Piotroski F-Score: 6
Altman Z-Score: 6.76
Beneish M-Score: -2.44
WACC vs ROIC
6.74%
16.11%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 20.60
RMD's Operating Margin % is ranked higher than
86% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.15 vs. RMD: 20.60 )
Ranked among companies with meaningful Operating Margin % only.
RMD' s Operating Margin % Range Over the Past 10 Years
Min: 17.11  Med: 21.76 Max: 26.05
Current: 20.6
17.11
26.05
Net Margin % 16.56
RMD's Net Margin % is ranked higher than
82% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. RMD: 16.56 )
Ranked among companies with meaningful Net Margin % only.
RMD' s Net Margin % Range Over the Past 10 Years
Min: 13.2  Med: 18.44 Max: 22.2
Current: 16.56
13.2
22.2
ROE % 19.03
RMD's ROE % is ranked higher than
85% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.37 vs. RMD: 19.03 )
Ranked among companies with meaningful ROE % only.
RMD' s ROE % Range Over the Past 10 Years
Min: 10.96  Med: 17.28 Max: 21.47
Current: 19.03
10.96
21.47
ROA % 10.19
RMD's ROA % is ranked higher than
77% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.13 vs. RMD: 10.19 )
Ranked among companies with meaningful ROA % only.
RMD' s ROA % Range Over the Past 10 Years
Min: 8.3  Med: 12.21 Max: 15.54
Current: 10.19
8.3
15.54
ROC (Joel Greenblatt) % 57.19
RMD's ROC (Joel Greenblatt) % is ranked higher than
86% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.96 vs. RMD: 57.19 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
RMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.78  Med: 48.94 Max: 58.32
Current: 57.19
24.78
58.32
3-Year Revenue Growth Rate 10.40
RMD's 3-Year Revenue Growth Rate is ranked higher than
63% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.80 vs. RMD: 10.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
RMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.9  Med: 20.65 Max: 32.3
Current: 10.4
7.9
32.3
3-Year EBITDA Growth Rate 3.50
RMD's 3-Year EBITDA Growth Rate is ranked higher than
52% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. RMD: 3.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
RMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 3.5  Med: 22.15 Max: 76.3
Current: 3.5
3.5
76.3
3-Year EPS without NRI Growth Rate 0.10
RMD's 3-Year EPS without NRI Growth Rate is ranked higher than
59% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. RMD: 0.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
RMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 20.95 Max: 66.7
Current: 0.1
0
66.7
GuruFocus has detected 6 Warning Signs with ResMed Inc $RMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» RMD's 30-Y Financials

Financials (Next Earnings Date: 2018-01-23 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

RMD Guru Trades in Q3 2016

Paul Tudor Jones 17,487 sh (+112.09%)
Jim Simons 1,421,600 sh (+80.25%)
Joel Greenblatt 296,383 sh (+12.71%)
Ken Fisher 20,950 sh (unchged)
John Hussman 2,300 sh (unchged)
Columbia Wanger 1,023,346 sh (-2.17%)
» More
Q4 2016

RMD Guru Trades in Q4 2016

Ken Fisher 20,950 sh (unchged)
John Hussman 2,300 sh (unchged)
Paul Tudor Jones Sold Out
Columbia Wanger 686,101 sh (-32.96%)
Jim Simons 385,300 sh (-72.90%)
Joel Greenblatt 12,933 sh (-95.64%)
» More
Q1 2017

RMD Guru Trades in Q1 2017

Caxton Associates 6,800 sh (New)
Steven Cohen 800 sh (New)
Paul Tudor Jones 24,495 sh (New)
Ken Fisher 20,950 sh (unchged)
John Hussman Sold Out
Columbia Wanger 640,313 sh (-6.67%)
Joel Greenblatt 9,715 sh (-24.88%)
Jim Simons 32,700 sh (-91.51%)
» More
Q2 2017

RMD Guru Trades in Q2 2017

Ken Fisher 20,950 sh (unchged)
Caxton Associates Sold Out
Jim Simons Sold Out
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Columbia Wanger 473,808 sh (-26.00%)
Paul Tudor Jones 7,983 sh (-67.41%)
» More
» Details

Insider Trades

Latest Guru Trades with RMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 Sold Out 0.01%$67.46 - $78.91 $ 77.388%0
Joel Greenblatt 2017-03-31 Reduce -24.88%$61.87 - $72.95 $ 77.3812%9,715
Joel Greenblatt 2016-12-31 Reduce -95.64%0.24%$57.34 - $65.16 $ 77.3826%12,933
Joel Greenblatt 2016-09-30 Add 12.71%0.03%$63.25 - $70.67 $ 77.3816%296,383
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:HOLX, NYSE:COO, NAS:XRAY, NYSE:WAT, NYSE:WST, NYSE:MTD, NYSE:HRC, NAS:ICUI, NYSE:CMD, NAS:PODD, NYSE:HAE, NYSE:HYH, NAS:MMSI, NAS:NXTM, NAS:OSUR, NAS:ATRI, NAS:IRTC, NYSE:GKOS, NAS:LMNX, NAS:LMAT » details
Traded in other countries:RMD.Australia, RME.Germany, RSMDF.USA,
Headquarter Location:USA
ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.

ResMed develops, manufactures, and distributes medical devices--such as airflow generators and masks--to treat breathing disorders. It also markets ventilation products, but sleep apnoea remains the company's primary focus. ResMed's reach is truly global, with distribution capabilities in more than 70 countries through wholly owned and independent firms. An increasing proportion of manufacturing capacity is in Singapore, with some still in Australia, where the company was founded.

Ratios

vs
industry
vs
history
PE Ratio 32.11
RMD's PE Ratio is ranked lower than
59% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. RMD: 32.11 )
Ranked among companies with meaningful PE Ratio only.
RMD' s PE Ratio Range Over the Past 10 Years
Min: 16.93  Med: 23.53 Max: 66.38
Current: 32.11
16.93
66.38
Forward PE Ratio 24.81
RMD's Forward PE Ratio is ranked higher than
74% of the 38 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.25 vs. RMD: 24.81 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.11
RMD's PE Ratio without NRI is ranked lower than
59% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.55 vs. RMD: 32.11 )
Ranked among companies with meaningful PE Ratio without NRI only.
RMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 16.93  Med: 23.51 Max: 64.76
Current: 32.11
16.93
64.76
Price-to-Owner-Earnings 35.46
RMD's Price-to-Owner-Earnings is ranked lower than
55% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.16 vs. RMD: 35.46 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
RMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.88  Med: 23.73 Max: 74.05
Current: 35.46
12.88
74.05
PB Ratio 5.61
RMD's PB Ratio is ranked lower than
75% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.29 vs. RMD: 5.61 )
Ranked among companies with meaningful PB Ratio only.
RMD' s PB Ratio Range Over the Past 10 Years
Min: 2.29  Med: 3.67 Max: 6.86
Current: 5.61
2.29
6.86
PS Ratio 5.33
RMD's PS Ratio is ranked lower than
67% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.24 vs. RMD: 5.33 )
Ranked among companies with meaningful PS Ratio only.
RMD' s PS Ratio Range Over the Past 10 Years
Min: 2.77  Med: 4.48 Max: 6.51
Current: 5.33
2.77
6.51
Price-to-Free-Cash-Flow 32.16
RMD's Price-to-Free-Cash-Flow is ranked lower than
57% of the 70 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.92 vs. RMD: 32.16 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
RMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.35  Med: 25.13 Max: 308.55
Current: 32.16
13.35
308.55
Price-to-Operating-Cash-Flow 26.61
RMD's Price-to-Operating-Cash-Flow is ranked lower than
62% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.25 vs. RMD: 26.61 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
RMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.7  Med: 18.65 Max: 44.03
Current: 26.61
10.7
44.03
EV-to-EBIT 25.19
RMD's EV-to-EBIT is ranked lower than
58% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.41 vs. RMD: 25.19 )
Ranked among companies with meaningful EV-to-EBIT only.
RMD' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.8  Med: 17.5 Max: 48.6
Current: 25.19
10.8
48.6
EV-to-EBITDA 20.14
RMD's EV-to-EBITDA is ranked lower than
59% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.62 vs. RMD: 20.14 )
Ranked among companies with meaningful EV-to-EBITDA only.
RMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.5  Med: 14.2 Max: 29.5
Current: 20.14
8.5
29.5
EV-to-Revenue 5.45
RMD's EV-to-Revenue is ranked lower than
66% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.43 vs. RMD: 5.45 )
Ranked among companies with meaningful EV-to-Revenue only.
RMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.5  Med: 4.2 Max: 6.3
Current: 5.45
2.5
6.3
PEG Ratio 5.02
RMD's PEG Ratio is ranked lower than
61% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. RMD: 5.02 )
Ranked among companies with meaningful PEG Ratio only.
RMD' s PEG Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.61 Max: 6.17
Current: 5.02
0.7
6.17
Shiller PE Ratio 40.64
RMD's Shiller PE Ratio is ranked higher than
59% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.16 vs. RMD: 40.64 )
Ranked among companies with meaningful Shiller PE Ratio only.
RMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 30.9  Med: 42.64 Max: 84.78
Current: 40.64
30.9
84.78
Current Ratio 4.57
RMD's Current Ratio is ranked higher than
78% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. RMD: 4.57 )
Ranked among companies with meaningful Current Ratio only.
RMD' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 3.95 Max: 6.19
Current: 4.57
1.65
6.19
Quick Ratio 3.82
RMD's Quick Ratio is ranked higher than
81% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. RMD: 3.82 )
Ranked among companies with meaningful Quick Ratio only.
RMD' s Quick Ratio Range Over the Past 10 Years
Min: 1.24  Med: 3.05 Max: 5.23
Current: 3.82
1.24
5.23
Days Inventory 106.30
RMD's Days Inventory is ranked higher than
64% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.43 vs. RMD: 106.30 )
Ranked among companies with meaningful Days Inventory only.
RMD' s Days Inventory Range Over the Past 10 Years
Min: 100.51  Med: 118.85 Max: 168.51
Current: 106.3
100.51
168.51
Days Sales Outstanding 79.57
RMD's Days Sales Outstanding is ranked lower than
74% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.12 vs. RMD: 79.57 )
Ranked among companies with meaningful Days Sales Outstanding only.
RMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 75.52  Med: 79.2 Max: 84.41
Current: 79.57
75.52
84.41
Days Payable 39.14
RMD's Days Payable is ranked lower than
68% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.69 vs. RMD: 39.14 )
Ranked among companies with meaningful Days Payable only.
RMD' s Days Payable Range Over the Past 10 Years
Min: 36.65  Med: 44.06 Max: 60.16
Current: 39.14
36.65
60.16

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.73
RMD's Dividend Yield % is ranked higher than
72% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. RMD: 1.73 )
Ranked among companies with meaningful Dividend Yield % only.
RMD' s Dividend Yield % Range Over the Past 10 Years
Min: 0.41  Med: 1.85 Max: 2.26
Current: 1.73
0.41
2.26
Dividend Payout Ratio 0.55
RMD's Dividend Payout Ratio is ranked higher than
53% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. RMD: 0.55 )
Ranked among companies with meaningful Dividend Payout Ratio only.
RMD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.45 Max: 0.55
Current: 0.55
0.32
0.55
3-Year Dividend Growth Rate 9.70
RMD's 3-Year Dividend Growth Rate is ranked higher than
78% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. RMD: 9.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
RMD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 20.8
Current: 9.7
0
20.8
Forward Dividend Yield % 1.81
RMD's Forward Dividend Yield % is ranked higher than
72% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. RMD: 1.81 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.73
RMD's 5-Year Yield-on-Cost % is ranked higher than
53% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. RMD: 1.73 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
RMD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41  Med: 1.85 Max: 2.26
Current: 1.73
0.41
2.26
3-Year Average Share Buyback Ratio -0.40
RMD's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.00 vs. RMD: -0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
RMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -44.2  Med: -2.25 Max: 2.6
Current: -0.4
-44.2
2.6

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 80.60
RMD's Price-to-Net-Current-Asset-Value is ranked lower than
98% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.23 vs. RMD: 80.60 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
RMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.63  Med: 9.17 Max: 91.88
Current: 80.6
1.63
91.88
Price-to-Tangible-Book 17.36
RMD's Price-to-Tangible-Book is ranked lower than
90% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. RMD: 17.36 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
RMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.5  Med: 6.21 Max: 31.13
Current: 17.36
1.5
31.13
Price-to-Intrinsic-Value-Projected-FCF 1.84
RMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.25 vs. RMD: 1.84 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
RMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.43  Med: 2.89 Max: 20.06
Current: 1.84
1.43
20.06
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.28
RMD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
86% of the 22 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. RMD: 1.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
RMD' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.64  Med: 0.88 Max: 1.69
Current: 1.28
0.64
1.69
Price-to-Median-PS-Value 1.19
RMD's Price-to-Median-PS-Value is ranked lower than
57% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. RMD: 1.19 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
RMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5  Med: 1.07 Max: 2.44
Current: 1.19
0.5
2.44
Price-to-Peter-Lynch-Fair-Value 5.98
RMD's Price-to-Peter-Lynch-Fair-Value is ranked lower than
78% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.48 vs. RMD: 5.98 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
RMD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.73  Med: 1.51 Max: 6.32
Current: 5.98
0.73
6.32
Price-to-Graham-Number 4.99
RMD's Price-to-Graham-Number is ranked lower than
89% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. RMD: 4.99 )
Ranked among companies with meaningful Price-to-Graham-Number only.
RMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.12  Med: 3.08 Max: 14.04
Current: 4.99
1.12
14.04
Earnings Yield (Greenblatt) % 3.97
RMD's Earnings Yield (Greenblatt) % is ranked higher than
65% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. RMD: 3.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
RMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.1  Med: 5.7 Max: 9.3
Current: 3.97
2.1
9.3
Forward Rate of Return (Yacktman) % 8.56
RMD's Forward Rate of Return (Yacktman) % is ranked higher than
52% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.23 vs. RMD: 8.56 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
RMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 8.5  Med: 18.1 Max: 29
Current: 8.56
8.5
29

More Statistics

Revenue (TTM) (Mil) $2,066.74
EPS (TTM) $ 2.41
Beta0.83
Short Percentage of Float6.60%
52-Week Range $56.59 - 81.87
Shares Outstanding (Mil)142.21

Analyst Estimate

Jun18 Jun19
Revenue (Mil $) 2,207 2,407
EPS ($) 3.09 3.50
EPS without NRI ($) 3.09 3.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.53%
Dividends per Share ($) 1.43 1.62
» More Articles for RMD

Headlines

Articles On GuruFocus.com
Big Data Yields Big Insights for Treatment of Central Sleep Apnea May 22 2017 
Clinical Trial Published in JAMA Offers New Hope for COPD Patients May 22 2017 
Introducing the Softest CPAP Mask from ResMed May 16 2017 
ResMed Unveils AirMini - the World's Smallest CPAP Apr 25 2017 
New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Slee Apr 06 2017 
ResMed to Announce Third Quarter Fiscal Year 2017 Results Mar 31 2017 
Columbia Wanger Boosts LivaNova, Sells Stericycle Aug 19 2016 
Battery Ventures-Backed Software Company Brightree LLC to Be Acquired for $800 Million Feb 23 2016 
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
These 7 Growth Stocks Have Potential To Make You Rich Sep 14 2014 

More From Other Websites
UBS has a playbook for New Zealand’s knife-edge election Sep 18 2017
See what the IHS Markit Score report has to say about ResMed Inc. Sep 18 2017
Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMed’s AirView Sep 12 2017
Why Is ResMed (RMD) Up 3.1% Since the Last Earnings Report? Sep 11 2017
Resmed Meets 80-Plus Relative Strength Rating Benchmark Sep 08 2017
ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : September 1, 2017 Sep 01 2017
ETFs with exposure to ResMed, Inc. : August 18, 2017 Aug 18 2017
3 Dividend Healthcare Stocks Aug 16 2017
Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4% Aug 16 2017
Edited Transcript of RMD earnings conference call or presentation 1-Aug-17 8:30pm GMT Aug 12 2017
Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for... Aug 11 2017
ResMed, Inc. :RMD-US: Earnings Analysis: 2017 By the Numbers : August 7, 2017 Aug 07 2017
ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : August 3, 2017 Aug 03 2017
ResMed Tops Expectations but Falls Anyway Aug 03 2017
ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track Aug 02 2017
ResMed beats 4Q profit forecasts Aug 01 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}